AzTrials
AzTrials

Skill PerformanceNCT07358741

Standard Two-Day Advanced Life Support (ALS) Versus One Day Recertification Course

An observational study of Skill Performance and Knowledge, run by National Hepatology & Tropical Medicine Research Institute at 1 site in Egypt.

Recruiting

Looking for participants now. Contact the study team or a site below to ask about taking part.

Sites and contacts
Official record
Search all trials

Trial summary

this study aims to compare the effectiveness of a one-day versus two-day ALS recertification course in terms of knowledge retention, practical skills performance, participant satisfaction, and confidence. Read more about this study

Who is it for?
Ages 18 years and olderHealthy volunteers can take part
Conditions the study is for
Skill Performance, Knowledge
How many people
158 participants
Where
1 siteEgypt
Study dates
12 Dec 2025to 30 Nov 2026
How long will I take part?
90 Days
Phase
Observational
Are there results?
Not yet: the study is under way

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 years and older
  • All sexes
  • Healthy volunteers accepted
  • Adult, Older adult

Study population: demographic data will be collected, including participants' age, sex, specialty, prior ALS course completion, participation in resuscitation teams, last CPR performance, and total online learning hours (minimum 16 hours for the standard ALS course and 8 hours for the recertification course).

Who may be able to join

  • Adult healthcare professionals (≥18 years) requiring ALS recertification, including doctors, nurses, and paramedics, who can attend the assigned course and follow-up assessments.

Who cannot join

  • Participants will be excluded if they cannot attend the assigned course or decline consent.

Trial locations and contacts

1 site in 1 country. Contact the study team or a site near you to ask about taking part.

Eman Ibrahim El-Desoki Mahmoud, MD, intensive care medicine contact

+2 01227409501

eman18350@gmail.com

Egypt1 site, 1 recruiting
  • Egyptian resuscitation council

    Cairo

    Eman prof., MD intensive care medicine, +201227409501, eman18350@gmail.com

    Eman, eman18350@gmail.com

    Recruiting

Other trials in Egypt

About this study

Official title: Balancing Time and Outcomes: A Prospective Observational Study Comparing the Effectiveness of the Standard Two-Day Advanced Life Support (ALS) Versus One Day Recertification Course

this study aims to compare the effectiveness of a one-day versus two-day ALS recertification course in terms of knowledge retention, practical skills performance, participant satisfaction, and confidence.

Read the detailed description

demographic data will be collected, including participants' age, sex, specialty, prior ALS course completion, participation in resuscitation teams, last CPR performance, and total online learning hours (minimum 16 hours for the standard ALS course and 8 hours for the recertification course). All ALS courses (standard and recertification) will be conducted in accordance with the standardized curriculum, structure, and educational formats established by the European Resuscitation Council (ERC).

Assessments:

  1. Knowledge Assessment B. Practical Skills Performance C. Participant satisfaction and confidence at the end of each course
  • Scoring: 0 = Not performed/incorrect, 1 = Partially/performed with prompting, 2 = Performed correctly and independently.
Keywords
Standard, recertification, ALS, ERC, knowledge retention

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

Study groups in NCT07358741
Study groupRoleWhat they receive
standard ALS courseTwo day course
Recertification Courseone day course

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. overall effectiveness between the two-day stanrdand one-day ALS recertification

    • Baseline knowledge score

    Measured: 24hours precourse

  2. Practical skill effectiveness

    • Standardized team-leader assessment station at the end of each course. Scoring: 0 = Not performed/incorrect, 1 = Partially/performed with prompting, 2 = Performed correctly and independently.

    Measured: 48 and 24 hours from standard amd recertification course respectively

  3. Knowledge retention assessment

    post-course MCQ to evaluate decay; similar to pre-course MCQ

    Measured: 3 months post course

Secondary outcomes (1)
  1. Participant satisfaction e

    scores about course structure, teaching quality, and learning materials; 1: Strongly disagree- 2:disagree- 3: moderate 4: agree- 5: Strongly agree

    Measured: 48hours and 24 from standard and recertification course respectively

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted22 Jan 2026
  2. Study start12 Dec 2025
  3. Primary completion30 Jun 2026 (estimated)
  4. Study completion30 Nov 2026 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Observational
Observational model
Cohort
Time perspective
Prospective
Enrolment
158 participants (estimated)
Target duration
90 Days
IDs, dates and publications
ClinicalTrials.gov ID
NCT07358741
Sponsor's protocol ID
NHTMRI-IRB-30-2025
Status last verified
Jan 2026
First submitted
9 Dec 2025
Last updated
22 Jan 2026
Results posted
No
Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
No: The individual participant data (IPD) generated in this study will not be made publicly available in order to protect participant confidentiality and comply with ethical regulations.

Questions about this trial

What is this clinical trial studying?

An observational study of Skill Performance and Knowledge, run by National Hepatology & Tropical Medicine Research Institute at 1 site in Egypt.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 1 inclusion and 1 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: looking for participants now, as of the sponsor's last update on 22 Jan 2026. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Egypt. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

This study is still under way. Results are not available in the source record yet.

How can a doctor refer a patient or contact the research team?

Contact Eman Ibrahim El-Desoki Mahmoud, MD, intensive care medicine (+2 01227409501, eman18350@gmail.com), or a site near the patient. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

overall effectiveness between the two-day stanrdand one-day ALS recertification (time frame: 24hours precourse). The study lists 3 primary outcomes in all. It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 22 Jan 2026.

Free account

Keep searching with a free account

You’ve used your 3 free searches for this session. Log in or create a free AzTrials account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in